Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.2862
S.2862: Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014
About This Bill
- Introduced Sept. 18, 2014
- Latest Major Action Sept. 18, 2014
Bill Sponsor
Bill Summary
Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 - Amends the Controlled Substances Act to direct the Attorney General, within 45 days of receiving a recommendation from the Secretary of Health and Human Services (HHS) to add a drug or substance that has never been marketed in the United States to a schedule of controlled substances, to issue an interim final rule under the exception for good cause, placing...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Sept. 18, 2014 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
Sept. 18, 2014 |
Introduced in the Senate by Orrin G. Hatch (R-Utah) |